FTC warning letters
This article was originally published in The Tan Sheet
The Federal Trade Commission warned 10 Web site operators to either prove or cease making "questionable claims" that their products, including supplements, can prevent, treat or cure H1N1 flu, according to a Nov. 16 release. The commission found the Web sites during a "swine flu surf" that was part of the commission's International Consumer Protection Enforcement Network's 11th Internet Sweep Sept. 21 through Sept. 25. FTC also referred 14 other Web site operators to foreign authorities
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.